Global Cancer Drugs Market Growth 2020-2025
According to this study, over the next five years the Cancer Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Cancer Drugs, covering the supply chain analysis, impact assessment to the Cancer Drugs market size growth rate in several scenarios, and the measures to be undertaken by Cancer Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
AstraZeneca
Novartis
Bristol-Myers Squibb
Amgen
Celgene
Takeda
Johnson & Johnson
Eli Lilly
Pfizer
Eisai
Otsuka
Teva
Astellas
Bayer
Sanofi
Ipsen
Biogen Idec
Merck & Co.
Merck KGaA
Gilead Sciences
AbbVie
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cancer Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Cancer Drugs market by identifying its various subsegments.
Focuses on the key global Cancer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cancer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cancer Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Drugs Consumption 2015-2025
2.1.2 Cancer Drugs Consumption CAGR by Region
2.2 Cancer Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy (Biologic Therapy)
2.2.5 Others
2.3 Cancer Drugs Consumption by Type
2.3.1 Global Cancer Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Cancer Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Cancer Drugs Sale Price by Type (2015-2020)
2.4 Cancer Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Other Cancers
2.5 Cancer Drugs Consumption by Application
2.5.1 Global Cancer Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Cancer Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Cancer Drugs Sale Price by Type (2015-2020)
3 Global Cancer Drugs by Company
3.1 Global Cancer Drugs Sales Market Share by Company
3.1.1 Global Cancer Drugs Sales by Company (2018-2020)
3.1.2 Global Cancer Drugs Sales Market Share by Company (2018-2020)
3.2 Global Cancer Drugs Revenue Market Share by Company
3.2.1 Global Cancer Drugs Revenue by Company (2018-2020)
3.2.2 Global Cancer Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Cancer Drugs Sale Price by Company
3.4 Global Cancer Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Cancer Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Cancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cancer Drugs by Regions
4.1 Cancer Drugs by Regions
4.2 Americas Cancer Drugs Consumption Growth
4.3 APAC Cancer Drugs Consumption Growth
4.4 Europe Cancer Drugs Consumption Growth
4.5 Middle East & Africa Cancer Drugs Consumption Growth
5 Americas
5.1 Americas Cancer Drugs Consumption by Countries
5.1.1 Americas Cancer Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Cancer Drugs Value by Countries (2015-2020)
5.2 Americas Cancer Drugs Consumption by Type
5.3 Americas Cancer Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cancer Drugs Consumption by Regions
6.1.1 APAC Cancer Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Cancer Drugs Value by Regions (2015-2020)
6.2 APAC Cancer Drugs Consumption by Type
6.3 APAC Cancer Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Cancer Drugs by Countries
7.1.1 Europe Cancer Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Cancer Drugs Value by Countries (2015-2020)
7.2 Europe Cancer Drugs Consumption by Type
7.3 Europe Cancer Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cancer Drugs by Countries
8.1.1 Middle East & Africa Cancer Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Cancer Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Cancer Drugs Consumption by Type
8.3 Middle East & Africa Cancer Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cancer Drugs Distributors
10.3 Cancer Drugs Customer
11 Global Cancer Drugs Market Forecast
11.1 Global Cancer Drugs Consumption Forecast (2021-2025)
11.2 Global Cancer Drugs Forecast by Regions
11.2.1 Global Cancer Drugs Forecast by Regions (2021-2025)
11.2.2 Global Cancer Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cancer Drugs Forecast by Type
11.8 Global Cancer Drugs Forecast by Application
12 Key Players Analysis
12.1 Roche
12.1.1 Company Information
12.1.2 Cancer Drugs Product Offered
12.1.3 Roche Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Roche Latest Developments
12.2 AstraZeneca
12.2.1 Company Information
12.2.2 Cancer Drugs Product Offered
12.2.3 AstraZeneca Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 AstraZeneca Latest Developments
12.3 Novartis
12.3.1 Company Information
12.3.2 Cancer Drugs Product Offered
12.3.3 Novartis Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Bristol-Myers Squibb
12.4.1 Company Information
12.4.2 Cancer Drugs Product Offered
12.4.3 Bristol-Myers Squibb Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Bristol-Myers Squibb Latest Developments
12.5 Amgen
12.5.1 Company Information
12.5.2 Cancer Drugs Product Offered
12.5.3 Amgen Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Amgen Latest Developments
12.6 Celgene
12.6.1 Company Information
12.6.2 Cancer Drugs Product Offered
12.6.3 Celgene Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Celgene Latest Developments
12.7 Takeda
12.7.1 Company Information
12.7.2 Cancer Drugs Product Offered
12.7.3 Takeda Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Takeda Latest Developments
12.8 Johnson & Johnson
12.8.1 Company Information
12.8.2 Cancer Drugs Product Offered
12.8.3 Johnson & Johnson Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Johnson & Johnson Latest Developments
12.9 Eli Lilly
12.9.1 Company Information
12.9.2 Cancer Drugs Product Offered
12.9.3 Eli Lilly Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Eli Lilly Latest Developments
12.10 Pfizer
12.10.1 Company Information
12.10.2 Cancer Drugs Product Offered
12.10.3 Pfizer Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Pfizer Latest Developments
12.11 Eisai
12.11.1 Company Information
12.11.2 Cancer Drugs Product Offered
12.11.3 Eisai Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Eisai Latest Developments
12.12 Otsuka
12.12.1 Company Information
12.12.2 Cancer Drugs Product Offered
12.12.3 Otsuka Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Otsuka Latest Developments
12.13 Teva
12.13.1 Company Information
12.13.2 Cancer Drugs Product Offered
12.13.3 Teva Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Teva Latest Developments
12.14 Astellas
12.14.1 Company Information
12.14.2 Cancer Drugs Product Offered
12.14.3 Astellas Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Astellas Latest Developments
12.15 Bayer
12.15.1 Company Information
12.15.2 Cancer Drugs Product Offered
12.15.3 Bayer Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Bayer Latest Developments
12.16 Sanofi
12.16.1 Company Information
12.16.2 Cancer Drugs Product Offered
12.16.3 Sanofi Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Sanofi Latest Developments
12.17 Ipsen
12.17.1 Company Information
12.17.2 Cancer Drugs Product Offered
12.17.3 Ipsen Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Ipsen Latest Developments
12.18 Biogen Idec
12.18.1 Company Information
12.18.2 Cancer Drugs Product Offered
12.18.3 Biogen Idec Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Biogen Idec Latest Developments
12.19 Merck & Co.
12.19.1 Company Information
12.19.2 Cancer Drugs Product Offered
12.19.3 Merck & Co. Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Merck & Co. Latest Developments
12.20 Merck KGaA
12.20.1 Company Information
12.20.2 Cancer Drugs Product Offered
12.20.3 Merck KGaA Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Merck KGaA Latest Developments
12.21 Gilead Sciences
12.21.1 Company Information
12.21.2 Cancer Drugs Product Offered
12.21.3 Gilead Sciences Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Gilead Sciences Latest Developments
12.22 AbbVie
12.22.1 Company Information
12.22.2 Cancer Drugs Product Offered
12.22.3 AbbVie Cancer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 AbbVie Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Cancer Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Chemotherapy
Table 5. Major Players of Targeted Therapy
Table 6. Major Players of Immunotherapy
Table 7. Major Players of Hormonal Therapy (Biologic Therapy)
Table 8. Major Players of Others
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 11. Global Cancer Drugs Revenue by Type (2015-2020) ($ million)
Table 12. Global Cancer Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Cancer Drugs Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 16. Global Cancer Drugs Value by Application (2015-2020)
Table 17. Global Cancer Drugs Value Market Share by Application (2015-2020)
Table 18. Global Cancer Drugs Sale Price by Application (2015-2020)
Table 19. Global Cancer Drugs Sales by Company (2017-2019) (K MT)
Table 20. Global Cancer Drugs Sales Market Share by Company (2017-2019)
Table 21. Global Cancer Drugs Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Cancer Drugs Revenue Market Share by Company (2017-2019)
Table 23. Global Cancer Drugs Sale Price by Company (2017-2019)
Table 24. Global Cancer Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Cancer Drugs Products Offered
Table 26. Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Cancer Drugs Consumption by Regions 2015-2020 (K MT)
Table 28. Global Cancer Drugs Consumption Market Share by Regions 2015-2020
Table 29. Global Cancer Drugs Value by Regions 2015-2020 ($ Millions)
Table 30. Global Cancer Drugs Value Market Share by Regions 2015-2020
Table 31. Americas Cancer Drugs Consumption by Countries (2015-2020) (K MT)
Table 32. Americas Cancer Drugs Consumption Market Share by Countries (2015-2020)
Table 33. Americas Cancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Cancer Drugs Value Market Share by Countries (2015-2020)
Table 35. Americas Cancer Drugs Consumption by Type (2015-2020) (K MT)
Table 36. Americas Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 37. Americas Cancer Drugs Consumption by Application (2015-2020) (K MT)
Table 38. Americas Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 39. APAC Cancer Drugs Consumption by Countries (2015-2020) (K MT)
Table 40. APAC Cancer Drugs Consumption Market Share by Countries (2015-2020)
Table 41. APAC Cancer Drugs Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Cancer Drugs Value Market Share by Regions (2015-2020)
Table 43. APAC Cancer Drugs Consumption by Type (2015-2020) (K MT)
Table 44. APAC Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 45. APAC Cancer Drugs Consumption by Application (2015-2020) (K MT)
Table 46. APAC Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 47. Europe Cancer Drugs Consumption by Countries (2015-2020) (K MT)
Table 48. Europe Cancer Drugs Consumption Market Share by Countries (2015-2020)
Table 49. Europe Cancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Cancer Drugs Value Market Share by Countries (2015-2020)
Table 51. Europe Cancer Drugs Consumption by Type (2015-2020) (K MT)
Table 52. Europe Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 53. Europe Cancer Drugs Consumption by Application (2015-2020) (K MT)
Table 54. Europe Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Cancer Drugs Consumption by Countries (2015-2020) (K MT)
Table 56. Middle East & Africa Cancer Drugs Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Cancer Drugs Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Cancer Drugs Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Cancer Drugs Consumption by Type (2015-2020) (K MT)
Table 60. Middle East & Africa Cancer Drugs Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Cancer Drugs Consumption by Application (2015-2020) (K MT)
Table 62. Middle East & Africa Cancer Drugs Consumption Market Share by Application (2015-2020)
Table 63. Cancer Drugs Distributors List
Table 64. Cancer Drugs Customer List
Table 65. Global Cancer Drugs Consumption Forecast by Countries (2021-2025) (K MT)
Table 66. Global Cancer Drugs Consumption Market Forecast by Regions
Table 67. Global Cancer Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Cancer Drugs Value Market Share Forecast by Regions
Table 69. Global Cancer Drugs Consumption Forecast by Type (2021-2025) (K MT)
Table 70. Global Cancer Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Cancer Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Cancer Drugs Value Market Share Forecast by Type (2021-2025)
Table 73. Global Cancer Drugs Consumption Forecast by Application (2021-2025) (K MT)
Table 74. Global Cancer Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Cancer Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Cancer Drugs Value Market Share Forecast by Application (2021-2025)
Table 77. Roche Product Offered
Table 78. Roche Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 79. Roche Main Business
Table 80. Roche Latest Developments
Table 81. Roche Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. AstraZeneca Product Offered
Table 83. AstraZeneca Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 84. AstraZeneca Main Business
Table 85. AstraZeneca Latest Developments
Table 86. AstraZeneca Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Novartis Product Offered
Table 88. Novartis Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 89. Novartis Main Business
Table 90. Novartis Latest Developments
Table 91. Novartis Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Bristol-Myers Squibb Product Offered
Table 93. Bristol-Myers Squibb Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 94. Bristol-Myers Squibb Main Business
Table 95. Bristol-Myers Squibb Latest Developments
Table 96. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Amgen Product Offered
Table 98. Amgen Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 99. Amgen Main Business
Table 100. Amgen Latest Developments
Table 101. Amgen Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Celgene Product Offered
Table 103. Celgene Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 104. Celgene Main Business
Table 105. Celgene Latest Developments
Table 106. Celgene Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Takeda Product Offered
Table 108. Takeda Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Takeda Main Business
Table 110. Takeda Latest Developments
Table 111. Takeda Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. Johnson & Johnson Product Offered
Table 113. Johnson & Johnson Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 114. Johnson & Johnson Main Business
Table 115. Johnson & Johnson Latest Developments
Table 116. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Eli Lilly Product Offered
Table 118. Eli Lilly Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 119. Eli Lilly Main Business
Table 120. Eli Lilly Latest Developments
Table 121. Eli Lilly Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Pfizer Product Offered
Table 123. Pfizer Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 124. Pfizer Main Business
Table 125. Pfizer Latest Developments
Table 126. Pfizer Basic Information, Company Total Revenue (in $ million), Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Eisai Product Offered
Table 128. Eisai Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 129. Eisai Main Business
Table 130. Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Eisai Latest Developments
Table 132. Otsuka Product Offered
Table 133. Otsuka Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 134. Otsuka Main Business
Table 135. Otsuka Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Otsuka Latest Developments
Table 137. Teva Product Offered
Table 138. Teva Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 139. Teva Main Business
Table 140. Teva Latest Developments
Table 141. Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 142. Astellas Product Offered
Table 143. Astellas Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 144. Astellas Main Business
Table 145. Astellas Latest Developments
Table 146. Astellas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 147. Bayer Product Offered
Table 148. Bayer Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 149. Bayer Main Business
Table 150. Bayer Latest Developments
Table 151. Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 152. Sanofi Product Offered
Table 153. Sanofi Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 154. Sanofi Main Business
Table 155. Sanofi Latest Developments
Table 156. Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 157. Ipsen Product Offered
Table 158. Ipsen Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 159. Ipsen Main Business
Table 160. Ipsen Latest Developments
Table 161. Ipsen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 162. Biogen Idec Product Offered
Table 163. Biogen Idec Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 164. Biogen Idec Main Business
Table 165. Biogen Idec Latest Developments
Table 166. Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 167. Merck & Co. Product Offered
Table 168. Merck & Co. Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 169. Merck & Co. Main Business
Table 170. Merck & Co. Latest Developments
Table 171. Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 172. Merck KGaA Product Offered
Table 173. Merck KGaA Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 174. Merck KGaA Main Business
Table 175. Merck KGaA Latest Developments
Table 176. Merck KGaA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 177. Gilead Sciences Product Offered
Table 178. Gilead Sciences Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 179. Gilead Sciences Main Business
Table 180. Gilead Sciences Latest Developments
Table 181. Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 182. AbbVie Product Offered
Table 183. AbbVie Cancer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 184. AbbVie Main Business
Table 185. AbbVie Latest Developments
Table 186. AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Cancer Drugs
Figure 2. Cancer Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cancer Drugs Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Cancer Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Chemotherapy
Figure 7. Product Picture of Targeted Therapy
Figure 8. Product Picture of Immunotherapy
Figure 9. Product Picture of Hormonal Therapy (Biologic Therapy)
Figure 10. Product Picture of Others
Figure 11. Global Cancer Drugs Consumption Market Share by Type (2015-2020)
Figure 12. Global Cancer Drugs Value Market Share by Type (2015-2020)
Figure 13. Cancer Drugs Consumed in Blood Cancer
Figure 14. Global Cancer Drugs Market: Blood Cancer (2015-2020) (K MT)
Figure 15. Global Cancer Drugs Market: Blood Cancer (2015-2020) ($ Millions)
Figure 16. Cancer Drugs Consumed in Breast Cancer
Figure 17. Global Cancer Drugs Market: Breast Cancer (2015-2020) (K MT)
Figure 18. Global Cancer Drugs Market: Breast Cancer (2015-2020) ($ Millions)
Figure 19. Cancer Drugs Consumed in Gastrointestinal Cancer
Figure 20. Global Cancer Drugs Market: Gastrointestinal Cancer (2015-2020) (K MT)
Figure 21. Global Cancer Drugs Market: Gastrointestinal Cancer (2015-2020) ($ Millions)
Figure 22. Cancer Drugs Consumed in Prostate Cancer
Figure 23. Global Cancer Drugs Market: Prostate Cancer (2015-2020) (K MT)
Figure 24. Global Cancer Drugs Market: Prostate Cancer (2015-2020) ($ Millions)
Figure 25. Cancer Drugs Consumed in Respiratory/Lung Cancer
Figure 26. Global Cancer Drugs Market: Respiratory/Lung Cancer (2015-2020) (K MT)
Figure 27. Global Cancer Drugs Market: Respiratory/Lung Cancer (2015-2020) ($ Millions)
Figure 28. Cancer Drugs Consumed in Other Cancers
Figure 29. Global Cancer Drugs Consumption Market Share by Application (2015-2020)
Figure 30. Global Cancer Drugs Value Market Share by Application (2015-2020)
Figure 31. Global Cancer Drugs Sales Market Share by Company in 2017
Figure 32. Global Cancer Drugs Sales Market Share by Company in 2019
Figure 33. Global Cancer Drugs Revenue Market Share by Company in 2017
Figure 34. Global Cancer Drugs Revenue Market Share by Company in 2019
Figure 35. Global Cancer Drugs Sale Price by Company in 2019
Figure 36. Global Cancer Drugs Consumption Market Share by Regions 2015-2020
Figure 37. Global Cancer Drugs Value Market Share by Regions 2015-2020
Figure 38. Americas Cancer Drugs Consumption 2015-2020 (K MT)
Figure 39. Americas Cancer Drugs Value 2015-2020 ($ Millions)
Figure 40. APAC Cancer Drugs Consumption 2015-2020 (K MT)
Figure 41. APAC Cancer Drugs Value 2015-2020 ($ Millions)
Figure 42. Europe Cancer Drugs Consumption 2015-2020 (K MT)
Figure 43. Europe Cancer Drugs Value 2015-2020 ($ Millions)
Figure 44. Middle East & Africa Cancer Drugs Consumption 2015-2020 (K MT)
Figure 45. Middle East & Africa Cancer Drugs Value 2015-2020 ($ Millions)
Figure 46. Americas Cancer Drugs Consumption Market Share by Countries in 2019
Figure 47. Americas Cancer Drugs Value Market Share by Countries in 2019
Figure 48. Americas Cancer Drugs Consumption Market Share by Type in 2019
Figure 49. Americas Cancer Drugs Consumption Market Share by Application in 2019
Figure 50. United States Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 51. United States Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Canada Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 53. Canada Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. Mexico Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 55. Mexico Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. APAC Cancer Drugs Consumption Market Share by Countries in 2019
Figure 57. APAC Cancer Drugs Value Market Share by Regions in 2019
Figure 58. APAC Cancer Drugs Consumption Market Share by Type in 2019
Figure 59. APAC Cancer Drugs Consumption Market Share by Application in 2019
Figure 60. China Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 61. China Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 62. Japan Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 63. Japan Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 64. Korea Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 65. Korea Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. Southeast Asia Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 67. Southeast Asia Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. India Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 69. India Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. Australia Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 71. Australia Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. Europe Cancer Drugs Consumption Market Share by Countries in 2019
Figure 73. Europe Cancer Drugs Value Market Share by Countries in 2019
Figure 74. Europe Cancer Drugs Consumption Market Share by Type in 2019
Figure 75. Europe Cancer Drugs Consumption Market Share by Application in 2019
Figure 76. Germany Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 77. Germany Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 78. France Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 79. France Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 80. UK Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 81. UK Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. Italy Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 83. Italy Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Russia Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 85. Russia Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. Middle East & Africa Cancer Drugs Consumption Market Share by Countries in 2019
Figure 87. Middle East & Africa Cancer Drugs Value Market Share by Countries in 2019
Figure 88. Middle East & Africa Cancer Drugs Consumption Market Share by Type in 2019
Figure 89. Middle East & Africa Cancer Drugs Consumption Market Share by Application in 2019
Figure 90. Egypt Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 91. Egypt Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 92. South Africa Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 93. South Africa Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 94. Israel Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 95. Israel Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 96. Turkey Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 97. Turkey Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 98. GCC Countries Cancer Drugs Consumption Growth 2015-2020 (K MT)
Figure 99. GCC Countries Cancer Drugs Value Growth 2015-2020 ($ Millions)
Figure 100. Global Cancer Drugs Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 101. Global Cancer Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 102. Americas Cancer Drugs Consumption 2021-2025 (K MT)
Figure 103. Americas Cancer Drugs Value 2021-2025 ($ Millions)
Figure 104. APAC Cancer Drugs Consumption 2021-2025 (K MT)
Figure 105. APAC Cancer Drugs Value 2021-2025 ($ Millions)
Figure 106. Europe Cancer Drugs Consumption 2021-2025 (K MT)
Figure 107. Europe Cancer Drugs Value 2021-2025 ($ Millions)
Figure 108. Middle East & Africa Cancer Drugs Consumption 2021-2025 (K MT)
Figure 109. Middle East & Africa Cancer Drugs Value 2021-2025 ($ Millions)
Figure 110. United States Cancer Drugs Consumption 2021-2025 (K MT)
Figure 111. United States Cancer Drugs Value 2021-2025 ($ Millions)
Figure 112. Canada Cancer Drugs Consumption 2021-2025 (K MT)
Figure 113. Canada Cancer Drugs Value 2021-2025 ($ Millions)
Figure 114. Mexico Cancer Drugs Consumption 2021-2025 (K MT)
Figure 115. Mexico Cancer Drugs Value 2021-2025 ($ Millions)
Figure 116. Brazil Cancer Drugs Consumption 2021-2025 (K MT)
Figure 117. Brazil Cancer Drugs Value 2021-2025 ($ Millions)
Figure 118. China Cancer Drugs Consumption 2021-2025 (K MT)
Figure 119. China Cancer Drugs Value 2021-2025 ($ Millions)
Figure 120. Japan Cancer Drugs Consumption 2021-2025 (K MT)
Figure 121. Japan Cancer Drugs Value 2021-2025 ($ Millions)
Figure 122. Korea Cancer Drugs Consumption 2021-2025 (K MT)
Figure 123. Korea Cancer Drugs Value 2021-2025 ($ Millions)
Figure 124. Southeast Asia Cancer Drugs Consumption 2021-2025 (K MT)
Figure 125. Southeast Asia Cancer Drugs Value 2021-2025 ($ Millions)
Figure 126. India Cancer Drugs Consumption 2021-2025 (K MT)
Figure 127. India Cancer Drugs Value 2021-2025 ($ Millions)
Figure 128. Australia Cancer Drugs Consumption 2021-2025 (K MT)
Figure 129. Australia Cancer Drugs Value 2021-2025 ($ Millions)
Figure 130. Germany Cancer Drugs Consumption 2021-2025 (K MT)
Figure 131. Germany Cancer Drugs Value 2021-2025 ($ Millions)
Figure 132. France Cancer Drugs Consumption 2021-2025 (K MT)
Figure 133. France Cancer Drugs Value 2021-2025 ($ Millions)
Figure 134. UK Cancer Drugs Consumption 2021-2025 (K MT)
Figure 135. UK Cancer Drugs Value 2021-2025 ($ Millions)
Figure 136. Italy Cancer Drugs Consumption 2021-2025 (K MT)
Figure 137. Italy Cancer Drugs Value 2021-2025 ($ Millions)
Figure 138. Russia Cancer Drugs Consumption 2021-2025 (K MT)
Figure 139. Russia Cancer Drugs Value 2021-2025 ($ Millions)
Figure 140. Spain Cancer Drugs Consumption 2021-2025 (K MT)
Figure 141. Spain Cancer Drugs Value 2021-2025 ($ Millions)
Figure 142. Egypt Cancer Drugs Consumption 2021-2025 (K MT)
Figure 143. Egypt Cancer Drugs Value 2021-2025 ($ Millions)
Figure 144. South Africa Cancer Drugs Consumption 2021-2025 (K MT)
Figure 145. South Africa Cancer Drugs Value 2021-2025 ($ Millions)
Figure 146. Israel Cancer Drugs Consumption 2021-2025 (K MT)
Figure 147. Israel Cancer Drugs Value 2021-2025 ($ Millions)
Figure 148. Turkey Cancer Drugs Consumption 2021-2025 (K MT)
Figure 149. Turkey Cancer Drugs Value 2021-2025 ($ Millions)
Figure 150. GCC Countries Cancer Drugs Consumption 2021-2025 (K MT)
Figure 151. GCC Countries Cancer Drugs Value 2021-2025 ($ Millions)
Figure 152. Roche Cancer Drugs Market Share (2018-2020)
Figure 153. AstraZeneca Cancer Drugs Market Share (2018-2020)
Figure 154. Novartis Cancer Drugs Market Share (2018-2020)
Figure 155. Bristol-Myers Squibb Cancer Drugs Market Share (2018-2020)
Figure 156. Amgen Cancer Drugs Market Share (2018-2020)
Figure 157. Celgene Cancer Drugs Market Share (2018-2020)
Figure 158. Takeda Cancer Drugs Market Share (2018-2020)
Figure 159. Johnson & Johnson Cancer Drugs Market Share (2018-2020)
Figure 160. Eli Lilly Cancer Drugs Market Share (2018-2020)
Figure 161. Pfizer Cancer Drugs Market Share (2018-2020)
Figure 162. Eisai Cancer Drugs Market Share (2018-2020)
Figure 163. Otsuka Cancer Drugs Market Share (2018-2020)
Figure 164. Teva Cancer Drugs Market Share (2018-2020)
Figure 165. Astellas Cancer Drugs Market Share (2018-2020)
Figure 166. Bayer Cancer Drugs Market Share (2018-2020)
Figure 167. Sanofi Cancer Drugs Market Share (2018-2020)
Figure 168. Ipsen Cancer Drugs Market Share (2018-2020)
Figure 169. Biogen Idec Cancer Drugs Market Share (2018-2020)
Figure 170. Merck & Co. Cancer Drugs Market Share (2018-2020)
Figure 171. Merck KGaA Cancer Drugs Market Share (2018-2020)
Figure 172. Gilead Sciences Cancer Drugs Market Share (2018-2020)
Figure 173. AbbVie Cancer Drugs Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets